- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.05. | DIH Holding US ändert Vereinbarung mit Investor | 1 | Investing.com Deutsch | ||
| 30.05. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| DIH HOLDING US Aktie jetzt für 0€ handeln | |||||
| 02.05. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.04. | DIH HOLDING US, INC. - 8-K, Current Report | - | SEC Filings | ||
| 14.03. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.03. | DIH HOLDING US, INC. - 8-K, Current Report | - | SEC Filings | ||
| 14.02. | DIH Holding US, Inc.: DIH Announces Third Quarter 2025 Financial Results | 225 | GlobeNewswire (Europe) | NORWELL, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual... ► Artikel lesen | |
| 14.02. | DIH HOLDING US, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.02. | DIH HOLDING US, INC. - 8-K, Current Report | - | SEC Filings | ||
| 04.02. | DIH Strengthens Strategic Alliance With Zahrawi Group | - | RTTNews | ||
| 04.02. | DIH und Zahrawi Group erweitern Partnerschaft auf Saudi-Arabien | 1 | Investing.com Deutsch | ||
| 04.02. | DIH expands strategic partnership with Zahrawi Group | - | Seeking Alpha | ||
| 04.02. | DIH HOLDING US, INC. - 8-K, Current Report | - | SEC Filings | ||
| 03.02. | DIH Holding US, Inc.: DIH Announces Closing of $4.6 Million Public Offering | 1 | GlobeNewswire (USA) | ||
| 31.01. | DIH announces pricing of $4.6M public offering | 1 | Seeking Alpha | ||
| 31.01. | DIH Holding legt Preis für öffentliches Angebot bei 0,7832 US-Dollar pro Einheit fest | 2 | Investing.com Deutsch | ||
| 31.01. | DIH Holding US, Inc.: DIH Announces Pricing of $4.6 Million Public Offering | 2 | GlobeNewswire (USA) | ||
| 28.01. | DIH Holding US, Inc.: DIH Announces Strategic Partnership with Nobis Rehabilitation Partners | 195 | GlobeNewswire (Europe) | NORWELL, Mass. and ALLEN, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate... ► Artikel lesen | |
| 28.01. | DIH HOLDING US, INC. - 8-K, Current Report | - | SEC Filings |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,111 | 0,00 % | Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy | Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,800 | +8,40 % | Ascendiant Capital raises Atossa Genetics stock price target to $7.50 | ||
| PING AN HEALTHCARE | 0,755 | 0,00 % | PA GOODDOCTOR (01833): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | ||
| MOUNTAIN VALLEY MD | 0,012 | -16,44 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,274 | +3,01 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| VERU | 0,525 | -3,40 % | Veru Inc.: Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide ... | --Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial... ► Artikel lesen | |
| CYTOSORBENTS | 0,884 | -4,54 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 5,240 | -100,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| VOLITIONRX | 0,568 | -3,57 % | VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, May 16 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., May 15, 2025 /PRNewswire/... ► Artikel lesen | |
| EKSO BIONICS | 0,257 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 02.06.2025 | The following instruments on XETRA do have their first trading 02.06.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.06.2025
Aktien
1 LU0445408270 Altisource Portfolio... ► Artikel lesen | |
| IMUNON | 1,340 | +1,52 % | IMNN-001 shows promise in ovarian cancer treatment | ||
| BEYOND AIR | 0,158 | -1,86 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 46,650 | +0,26 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 44,290 | +0,11 % | DAX-Check LIVE: Bilfinger, Cancom, Delivery Hero, Fresenius, Gerresheimer, Rheinmetall im Fokus | Der DAX hat den gestrigen Handelstag mit leichten Verlusten beendet. Der deutsche Leitindex schloss 0,28 Prozent tiefer bei 23.930 Punkten. Zwar konnte er sich am Nachmittag vom Tagestief bei 23.740... ► Artikel lesen |
DIH HOLDING US INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -2,24 % bei einem Aktienkurs von 0,222 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DIH HOLDING US INC finden Sie auf Wallstreet Online.